Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-017148
Filing Date
2023-03-08
Accepted
2023-03-08 16:00:28
Documents
1
Period of Report
2023-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5706
  Complete submission text file 0001209191-23-017148.txt   7102
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TREVI THERAPEUTICS, INC. 195 CHURCH STREET, FLOOR 14 NEW HAVEN CT 06510
Business Address
Simon Farrell (Reporting) CIK: 0001965585 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38886 | Film No.: 23716081